Glutathione's poor oral bioavailability means most formulations deliver negligible intracellular benefit, regardless of marketing claims about 'reduced' or 'liposomal' preparations
However, studies have shown that antioxidant approaches, including anti-neuroinflammatory and neuroprotective agents, may have therapeutic efficacy in the treatment of PD ( The interplay between mitochondrial function and GSH is especially critical in PD
Secondly, the bathochromic shift accompanying the reaction, from the reagent maximum at 274 nm to that of derivative at 315 nm, is analytically advantageous 32
To counteract this process, the body has to produce new molecules of glutathione
Unfortunately, the therapeutic potential of NAC in bone tissue pathology has not been substantiated by clinical trials ( underscoring the need for further in vivo research